Brisbane, June 25, 2026, 08:08 AEST
- Shares finished Wednesday at A$22.93, gaining 1.42%. This was ahead of the ASX open on Thursday.
- ALS Global set the A$22.93 dividend reinvestment price off the five-day VWAP from June 17 to 23, no discount applied.
- June 19 made up 53% of the pricing window’s total volume and traded at 4.85 times its 20-day average, Reuters calculated.
ALS Ltd closed Wednesday at the same level as its final-dividend DRP price, with trading over five sessions shaped by the June index rebalance. The cash market moved into pre-open at 08:08 AEST Thursday.
Macquarie Securities (Australia), a Macquarie Group Ltd (ASX:MQG) unit, was tapped to buy ALS shares on market during the pricing period under the plan. ALS said it would only issue new shares if that purchase couldn’t go through.
ALS joined the S&P/ASX 50 before the start on June 22, in the same window that saw Pro Medicus Ltd (ASX:PME) dropped from the index. That landed the index reshuffle and the DRP trades in the same price window.
Friday, June 19, saw 8,376,829 shares change hands for A$189.8 million in turnover, with the stock retreating 3.25% to A$22.60. Reuters calculated that trading volume was 4.85 times the average of the past 20 sessions. The day’s trades made up 53% of the 15.81 million shares exchanged through the DRP window.
Shares finished Monday up 1.28% at A$22.89, then lost 1.22% Tuesday to close at A$22.61. The stock bounced 1.42% Wednesday and closed the run 1.46% higher than the rebalance-day finish. Trading back to the DRP price shows Friday’s big volume didn’t lock in much of a discount by Wednesday, but the public trade data don’t show who was behind the buying or selling.
ALS set a final dividend of A$117.2 million at 23.1 Australian cents per share. Reinvesting that full amount at A$22.93 a share would put the upper limit at about 5.11 million shares, or 32% of total volume in the pricing window. That’s almost triple the past 20-session average. The number is a cap, not an estimate, since it counts every dollar of the dividend as going into shares.
ALS finished Wednesday trading at around 30.3 times expected FY26 underlying EPS of 75.7 cents and 36.2 times on statutory EPS of 63.3 cents. The full-year dividend of 42.5 cents gave a 1.85% yield. Shares closed 12.4% under their 52-week high of A$26.17.
ALS (ASX: ALQ) posted a 10.7% lift in FY26 revenue to A$3.32 billion and a 25.8% jump in underlying net profit to A$381.2 million. Minerals margin was 33.0%. Chairman Nigel Garrard said ALS was “benefitting from the more buoyant conditions in mineral exploration markets.” ALS is guiding for mid-to-high single-digit organic revenue growth at the group level in FY27, and 13%-15% growth for Minerals. Life Sciences organic revenue was up 2.8%. ALS estimates A$5 million to A$10 million in Middle East supply-chain earnings exposure. For every 1% currency move against the Australian dollar, annual underlying net profit shifts by around A$2 million. ASX Announcements
DRP shares and the cash dividend are set for July 3. ALS holds its annual meeting July 28.
